Drug intelligence / Profile preview

molsidomine

Development stage
Phase 4
Lead developer
Takeda
Modality
Small Molecules
Administration
Oral
01

Overview

Molsidomine is an orally active, long-acting vasodilator of the syndnone class used primarily for the prevention and long-term treatment of stable and unstable angina pectoris, including in patients with left heart failure or following acute myocardial infarction. It acts as a prodrug that is metabolized in the liver to linsidomine (SIN-1), which then releases nitric oxide (NO). The NO stimulates soluble guanylate cyclase, increasing cyclic GMP levels and leading to relaxation of vascular smooth muscle, resulting in vasodilation and reduced myocardial oxygen demand. Unlike organic nitrates, molsidomine does not induce tolerance with prolonged use. It also has antiplatelet effects due to its mechanism of action[1][2][6][8].

Brand names
CorvasalCorvaton
Other names
MolsidominaMolsidominum
02

Targets

GUCY1A2 (Guanylate cyclase soluble subunit alpha-2)

Beyond the preview

Go deeper on molsidomine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on molsidomine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call